SA
Log In
ALNY
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
28 analysts·High coverage
71
Score
23 Buy (82%)5 Hold (18%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
2382%
Hold
518%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$351.00
+17.8%
Consensus
$445.50
+49.5%
Bull
$530.00
+77.9%
12-Month Target Range28 analysts
$351.00$445.50$530.00
Current $297.93Consensus
Current Price
$297.93
Upside to Consensus
$147.57

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+31.37%
EPS+46.10%
FY2028
Rev+19.45%
EPS+25.71%
FY2029
Rev+15.28%
EPS+19.05%

Earnings Surprises

Recent Analyst Actions

May 1, 2026Morgan Stanley
Alnylam price target raised to $370 from $360 at Morgan Stanley
Target:$370.00
+22.7%from $301.45
May 1, 2026Bernstein
Alnylam price target lowered to $447 from $448 at Bernstein
Target:$447.00
+47.6%from $302.85
Feb 17, 2026Canaccord Genuity
Alnylam price target raised to $429 from $415 at Canaccord
Target:$429.00
+36.5%from $314.40
Feb 13, 2026Morgan Stanley
Alnylam price target lowered to $360 from $408 at Morgan Stanley
Target:$360.00
+14.7%from $313.75
Feb 13, 2026Bernstein
Alnylam price target lowered to $451 from $491 at Bernstein
Target:$451.00
+44.4%from $312.43
Feb 13, 2026Chardan Capital
Alnylam price target lowered to $425 from $475 at Chardan
Target:$425.00
+37.8%from $308.48
Feb 12, 2026Stifel Nicolaus
Alnylam price target lowered to $444 from $508 at Stifel
Target:$444.00
+41.8%from $313.05
Jan 30, 2026H.C. Wainwright
Alnylam price target lowered to $510 from $570 at H.C. Wainwright
Target:$510.00
+47.1%from $346.79
Jan 20, 2026RBC Capital
Alnylam price target lowered to $465 from $500 at RBC Capital
Target:$465.00
+29.5%from $359.00
Jan 20, 2026Wells Fargo
Alnylam price target lowered to $376 from $479 at Wells Fargo
Target:$376.00
+4.7%from $359.00
Jan 12, 2026Needham
Alnylam price target raised to $529 from $520 at Needham
Target:$529.00
+32.8%from $398.29
Jan 12, 2026Raymond James
Raymond James Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)
Target:$472.00
+18.5%from $398.29
Jan 8, 2026Truist Financial
Alnylam price target lowered to $530 from $535 at Truist
Target:$530.00
+26.5%from $419.07
Jan 6, 2026Bernstein
Alnylam price target lowered to $491 from $525 at Bernstein
Target:$491.00
+26.7%from $387.44
Dec 15, 2025Leerink Partners
Alnylam price target lowered to $351 from $370 at Leerink
Target:$351.00
-12.1%from $399.42
Dec 11, 2025Stifel Nicolaus
Alnylam price target raised to $508 from $495 at Stifel
Target:$508.00
+25.6%from $404.46
Nov 4, 2025H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Target:$570.00
+31.3%from $434.07
Oct 31, 2025Barclays
Alnylam price target raised to $527 from $460 at Barclays
Target:$527.00
+17.2%from $449.56
Oct 31, 2025Oppenheimer
Alnylam Pharmaceuticals (ALNY) PT Raised to $500 at Oppenheimer
Target:$500.00
+11.2%from $449.56
Oct 31, 2025Chardan Capital
Alnylam price target raised to $475 from $400 at Chardan
Target:$475.00
+5.7%from $449.56
Oct 30, 2025UBS
Alnylam price target lowered to $549 from $550 at Jefferies
Target:$549.00
+22.1%from $449.56
Oct 30, 2025Morgan Stanley
Alnylam price target raised to $495 from $475 at Morgan Stanley
Target:$495.00
+10.1%from $449.56
Oct 22, 2025Cantor Fitzgerald
Alnylam price target raised to $450 from $325 at Cantor Fitzgerald
Target:$450.00
-5.1%from $474.00
Oct 17, 2025Truist Financial
Alnylam price target raised to $535 from $459 at Truist
Target:$535.00
+11.6%from $479.19
Oct 6, 2025Morgan Stanley
Alnylam price target raised to $475 from $405 at Morgan Stanley
Target:$475.00
+4.1%from $456.35

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance